SOURCE: Ubiquitech Software Corp.

Ubiquitech Software Corp.

May 05, 2016 08:30 ET

HempLife Today Debuts New CannazALL Liquid Soluble CBD Powder; Product Sales Exceed $10,000 During First 48 Hours

DENVER, CO--(Marketwired - May 5, 2016) - Ubiquitech Software Corp. (OTC PINK: UBQU), through its operating subsidiary HempLife Today™ (www.hemplife.com), has debuted its newest hemp CBD (Cannabidiol) product, Liquid Soluble CBD Powder. Online sales of this product exceeded $10,000 in the first 48 hours, indicating a great popularity for this new and exciting CannazALL™ hemp CBD product.

The initial results on this product are stunning because the company only offered it to a select few customers over the weekend of April 22nd, and the results continue to be overwhelming as orders are still coming in as of this release.

This new CannazALL™ CBD Powder mixes with any liquid and is recommended to be used with the following beverages; purified water, tea, coffee, drinks, and even smoothies, shakes, foods and soups. The company believes this is a great addition to the CannazALL™ CBD brand and offers customers another easy and very portable method to take its hemp CBD products.

"We've been working on this product for months," said Tim Zorn, CEO of HempLifeToday™. "Now we have a perfected formula that blends beautifully with liquids. We expect great things from this product as we penetrate deeper into the marketplace."

CBD products derived from hemp are becoming more popular on a daily basis and HempLifeToday™ seeks to be the leader with its popular and growing brand of CannazALL™ CBD products. It is estimated that less than 5% of the general population is aware that CBD derived from hemp is available and legal in all 50 states. Many people have claimed that CBD therapy helps with...Antibiotic-resistant infections, Immuno-suppressive, Rheumatoid arthritis, Psoriasis, PTSD, Anxiety, Vascular and muscle relaxing, Diabetes, Alcoholism, Spasm, MS, Epilepsy, Chronic pain, and Schizophrenia & Psychosis. As the awareness of this product grows and HempLifeToday™ continues the aggressive marketing of the CannazALL™ brand, the company expects sales to climb exponentially in the weeks, months, and years ahead.

"Of all the products we've been involved with over the years, nothing compares to the potential of our CannazALL™ brand," said Jim Ballas, CEO of UBQU. "I personally have been involved in general merchandise offers, Infomercials and DRTV, even memorabilia for the most popular Rock bands ever... But, CannazALL™ continues to show it has a need and a popularity that can hit the stratosphere and we are only at the very beginning. The sky is the limit with this incredible product." CannazALL™ Liquid Soluble Powder is available on the Website @ www.HempLifeToday.com along with all of the popular CannazALL™ CBD products and starts at 1,000 mg for just $98.

About Ubiquitech Software Corp.

Ubiquitech Software Corp., through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response Television (DRTV), Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday.com™

HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed four CannazALL™ CBD oil products that include its popular CBD Tinctures, Oils, Capsules, Powder, and e-liquid.

This press release contains forward-looking statements. Words such as "expects", "intends'', "believes'', and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact Information